Literature DB >> 12172365

Survival statistics gone awry: pancreatic cancer, a case in point.

Birgir Gudjonsson1.   

Abstract

Resections for pancreatic cancer have been performed for 65 years, with approximately 20,000 reported. A number of authors claim a 5-year survival rate of 30% to 58%. Review of the literature reveals only about 1,200 5-year survivors; however, 10 times as many individual resected survivors have been reported (in various countries), and nonresected survivors are overlooked. This high survival percentage is obtained by reducing the subset on which calculations are based and by using methods such as the Kaplan-Meier method, which produces higher figures as increasing numbers of patients are lost to follow-up. After adjustments, hardly more than 350 resected survivors could be found. Revision of statistical methods is urgently needed.

Entities:  

Mesh:

Year:  2002        PMID: 12172365     DOI: 10.1097/00004836-200208000-00011

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  23 in total

Review 1.  Systematic review of actual 10-year survival following resection for hepatocellular carcinoma.

Authors:  Annelise M Gluer; Nicholas Cocco; Jerome M Laurence; Emma S Johnston; Michael J Hollands; Henry C C Pleass; Arthur J Richardson; Vincent W T Lam
Journal:  HPB (Oxford)       Date:  2012-02-28       Impact factor: 3.647

2.  Underutilization of surgical resection in patients with localized pancreatic cancer.

Authors:  Taylor S Riall; Keith D Lillemoe
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

3.  Preoperative platelet count and survival prognosis in resected pancreatic ductal adenocarcinoma.

Authors:  Ismael Domínguez; Stefano Crippa; Sarah P Thayer; Yin P Hung; Cristina R Ferrone; Andrew L Warshaw; Carlos Fernández-Del Castillo
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

Review 4.  Endoscopic ultrasound elastography for differentiating between pancreatic adenocarcinoma and inflammatory masses: a meta-analysis.

Authors:  Xiang Li; Wei Xu; Jian Shi; Yong Lin; Xin Zeng
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

5.  Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.

Authors:  M Carpelan-Holmström; S Nordling; E Pukkala; R Sankila; J Lüttges; G Klöppel; C Haglund
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 6.  Mesopancreas in pancreatic cancer: where do we stand - review of literature.

Authors:  Ramachandra Chowdappa; Vasu Reddy Challa
Journal:  Indian J Surg Oncol       Date:  2014-02-22

7.  A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer.

Authors:  Thomas J Howard; Joseph E Krug; Jian Yu; Nick J Zyromski; C Max Schmidt; Lewis E Jacobson; James A Madura; Eric A Wiebke; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

Review 8.  Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?

Authors:  H G Smeenk; T C K Tran; J Erdmann; C H J van Eijck; J Jeekel
Journal:  Langenbecks Arch Surg       Date:  2004-05-14       Impact factor: 3.445

Review 9.  Pancreatic cancer - a continuing challenge in oncology.

Authors:  Attila Zalatnai
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

10.  The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials.

Authors:  J Gaedcke; B Gunawan; M Grade; R Szöke; T Liersch; H Becker; B M Ghadimi
Journal:  Langenbecks Arch Surg       Date:  2009-05-06       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.